Dr. Saidu Sulaiman Kamara

NAME: Dr. Saidu Sulaiman Kamara PhD

COMPANY: Higher Education

PROFESSION: Lecturer/ Research Scientist

CATEGORIES NOMINATED: Outstanding Achievement in Health

CITY: Wenzhou City, Zhejiang Province

COUNTRY BASE: China

NATIONALITY:  Sierra Leonean

INSTAGRAM: Nil

LinkedIn: Saidu S. Kamara

Academic Achievement:

  • Zhejiang Government Scholarship winner (2021)
  • Zhejiang Government Scholarship winner (2020)
  • Wenzhou Medical University MD-PHD scholarship winner (2016-2021).
  • Chinese government scholarship winner (2009-2015).

International Scientific Publications:

  • EBV LMP1-C binding affibody molecule downregulates MEK/ERK p90RSK pathway and inhibits the proliferation of nasopharyngeal carcinoma cells in mouse tumor xenograft models [Switzerland, 2023].
  •  Novel EBV LMP1 C‑terminal domain binding affibody molecules as potential agents for in vivo molecular imaging diagnosis of nasopharyngeal carcinoma [Germany, 2021].
  •  Novel affibody molecules targeting the HPV E6 oncoprotein inhibited the proliferation of cervical cancer cells [Switzerland, 2021].
  • Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of NPC cells

[England,2020].

  • Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma [USA, 2020].
  • Novel Affibody Molecules Specifically Bind to SARS-CoV-2 Spike Protein and Efficiently Neutralize Delta and Omicron Variant [USA, 2023]

Leave a Reply

Your email address will not be published. Required fields are marked *